Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
50.00% $0.0003
America/New_York / 19 apr 2024 @ 11:51
FUNDAMENTALS | |
---|---|
MarketCap: | 0.0032 mill |
EPS: | -2.65 |
P/E: | 0 |
Earnings Date: | Apr 22, 2024 |
SharesOutstanding: | 10.72 mill |
Avg Daily Volume: | 0.0029 mill |
RATING 2024-04-19 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/21 | 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ -0.0007 - 0.0013 ( +/- 333.33%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-03 | Basta Steven L | Buy | 72 000 | Restricted Stock Unit |
2023-01-03 | Durbin Scott | Buy | 360 000 | Restricted Stock Unit |
2023-01-03 | Jorn Debora | Buy | 36 000 | Restricted Stock Unit |
2023-01-03 | Morris Arlene | Buy | 36 000 | Restricted Stock Unit |
2023-01-03 | Presnell Sharon Collins | Buy | 36 000 | Restricted Stock Unit |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 10 454 912 | Sell: 347 991 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.0003 (50.00% ) |
Volume | 0.0001 mill |
Avg. Vol. | 0.0029 mill |
% of Avg. Vol | 5.13 % |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.